We could not find any results for:
Make sure your spelling is correct or try broadening your search.
HERZLIYA, Israel and CALGARY, Alberta, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in chronic pain...
NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HERZLIYA, Israel and CALGARY, Alberta, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Innocan Pharma...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.013 | -10.9243697479 | 0.119 | 0.121 | 0.107 | 367097 | 0.11250106 | DE |
4 | -0.023 | -17.8294573643 | 0.129 | 0.1395 | 0.107 | 271103 | 0.1193868 | DE |
12 | -0.032 | -23.1884057971 | 0.138 | 0.1595 | 0.107 | 317543 | 0.1298457 | DE |
26 | -0.057 | -34.9693251534 | 0.163 | 0.18 | 0.107 | 289204 | 0.14348785 | DE |
52 | -0.0922 | -46.5186680121 | 0.1982 | 0.236 | 0.107 | 347361 | 0.17382751 | DE |
156 | -0.149 | -58.431372549 | 0.255 | 0.2884999 | 0.107 | 353476 | 0.18956623 | DE |
260 | -0.149 | -58.431372549 | 0.255 | 0.2884999 | 0.107 | 353476 | 0.18956623 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions